Related Experiment Video
Updated: Dec 25, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Multi-network logistic matrix factorization for metabolite-disease interaction prediction
Yingjun Ma1,2, Tingting He1,3, Xingpeng Jiang1,3
1School of Computer, Central China Normal University, Wuhan, China.
Abstract:
Identifying disease-related metabolites is of great significance for the diagnosis, prevention, and treatment of disease. In this study, we propose a novel computational model of multiple-network logistic matrix factorization (MN-LMF) for predicting metabolite-disease interactions, which is especially relevant for new diseases and new metabolites. First, MN-LMF builds disease (or metabolite) similarity network by integrating heterogeneous omics data. Second, it combines these similarities with known metabolite-disease interaction networks, using modified logistic matrix factorization to predict potential metabolite-disease interactions. Experimental results show that MN-LMF accurately predicts metabolite-disease interactions, and outperforms other state-of-the-art methods. Moreover, case studies also demonstrated the effectiveness of the model to infer unknown metabolite-disease interactions for novel diseases without any known associations.
More Related Videos
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Mechanistic Models: Overview of Compartment Models

